Default company panoramic image

Convergent Life Sciences, Inc.

Convergent develops efficacious and cost-effective solutions for the accurate detection and targeted treatment of prostate cancer.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Roseville, CA, USA
  • Currency USD
  • Website

Company Summary

Convergent Life Sciences, Inc. is a medical device company that develops efficacious, cost-effective and highly scalable technologies to enable better detection, management, and treatment of prostate cancer. Convergent's image fusion, guidance, and fusion guided ablation solutions enable targeted focal therapy that destroys the cancer while sparing surrounding healthy tissue.


  • Default avatar
    Amit Vohra, PhD
    Chief Executive Officer

    Dr. Amit Vohra is the former Vice President of Strategy & Operations of Eigen, where he invented and commercialized the first FDA cleared targeted biopsy and fusion devices. He also held the position of Vice President of Business Development at Advanced Biopharma Consulting.

  • Default avatar
    Dan Sperling, MD

    Dr. Dan Sperling is the Medical Director and Chief of Radiology at the New Jersey Institute of Radiology. Certified by the American Board of Radiology, Dr. Sperling is an accomplished leader in the diagnosis and treatment of prostate tumors through MRI and laser ablation procedures.

  • Default avatar
    Dinesh Kumar, PhD
    Chief Operating Officer & Chief Technology Officer

    Dr. Dinesh Kumar is the former Vice President of R&D and Engineering of Eigen, where he invented and commercialized the first FDA cleared targeted biopsy and multi-modality fusion devices. He holds over 15 issued and pending patents.

  • Default avatar
    Herbert Lepor, MD
    Chief Medical Officer

    Dr. Herbert Lepor is the Chairman of NYU’s Department of Urology, and the Director of the Smilow Comprehensive Prostate Cancer Center. He is the co-founder and editor of Reviews in Urology. Dr. Lepor is a world renowned expert in the field of urology and prostate diseases.


  • Default avatar
    Latham & Watkins LLP; Ostrolenk Faber LLP (IP)
    Default avatar
    MFA - Moody, Famiglietti & Andronico, LLP